Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation-Reference-Cited by-同舟云学术

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation

Published:2000-02 Issue:2 Volume:31 Page:496-501
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sánchez-Fueyo Alberto,Rimola Antoni,Grande Luis,Costa Josep,Mas Antoni,Navasa Miguel,Cirera Isabel,Sánchez-Tapias Jose Maria,Rodés Juan

Publisher

Wiley

Subject

Hepatology

Reference31 articles.

1. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis;Davies;Hepatology,1991

2. Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation;Freeman;Transplantation,1991

3. Orthotopic liver transplantation for patients with hepatitis B virus- related liver disease;Todo;Hepatology,1991

4. Liver transplantation in European patients with the hepatitis B surface antigen;Samuel;N Engl J Med,1993

5. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts;Lauchart;Transplant Proc,1987

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination of Immunocompromised Hosts;Plotkin's Vaccines;2023

2. Recurrence of the Primary Liver Disease;Textbook of Liver Transplantation;2022

3. Efficacy and Safety of Hepatitis B Virus Vaccination Following Hepatitis B Immunoglobulin Withdrawal After Liver Transplantation;Transplantation Proceedings;2021-12

4. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation;Alimentary Pharmacology & Therapeutics;2021-07-19

5. S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11);Zeitschrift für Gastroenterologie;2021-07